An observational study in Acute Respiratory Distress Syndrome, sponsored by Sanatorio Anchorena San Martin. Completed at 1 site in Argentina. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2021-09-30.
Sponsored by Sanatorio Anchorena San Martin · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Respiratory Distress Syndrome with a site in Argentina — 6 open to participants now, 7 under way, 1 of them phase 3. Respiratory Distress Syndrome · Argentina.
Among the 21 studies in Respiratory Distress Syndrome with a site in Argentina, this one is the 5th largest by enrollment of the 12 observational ones that give a count, is one of 5 that started in 2020, is one of 12 observational ones, and was the 6th registered.
1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.
Browse Respiratory Distress Syndrome studies →6 of the 21 studies in Respiratory Distress Syndrome with a site in Argentina are open now. Recruiting first, the newest first:
Hospital de Alta Complejidad en Red · Sites in Argentina
Ages 1 mo–14 yrs
Pontificia Universidad Catolica de Chile · Sites in Argentina, Chile, Colombia and 3 more countries
Ages 18+
Hospital El Cruce · Sites in Argentina
Ages 18–75
AstraZeneca · Sites in Argentina, United States, Australia and 36 more countries
Ages 18+
Ramos Mejía Hospital · Sites in Argentina
Ages 15+
A study can be open while its sites in Argentina have not opened yet or have stopped. Only those recruiting at a site in Argentina →
Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 5 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 45 is below the median of 100 across 476 observational studies indexed under Respiratory Distress Syndrome.
Median enrollment 107 across the 9 interventional studies, 40 across the 12 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 21 have an industry lead sponsor. The 10 most frequent:
Sanatorio Anchorena San Martin is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Sanatorio Anchorena San Martin has 3 studies filed under Respiratory Distress Syndrome — fewer than ten, so there is no comparison to draw.
2 of the studies in Respiratory Distress Syndrome with a site in Argentina that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
| NCT06854627Pontificia Universidad Catolica de ChileEffect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS | 2027-10 |
Add all 2 to your calendar (.ics) → With an account.
Among the 21 studies in Respiratory Distress Syndrome with a site in Argentina, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The primary objective of the study is to compare the mechanical power applied to the respiratory system in patient with acute respiratory distress syndrome in supine positioning and after the implementation of prone positioning while mantaining the same ventilatory setting.
The secondary objetive of the study is to compare the mechanical power applied to the respiratory system in patient with acute respiratory distress syndrome in supine positioning and after the implementation of prone positioning and adjusting an individualized ventilatory setting.
Data of mechanical power will be collected prospectively in three different times:
Besides, the investigators will take an arterial blood sample in T0 and T2 to calculate changes in oxygenation status and ventilatory ratio.
In case that esophageal manometry is available, the investigators will collect data regarding to transpulmonary and esophageal pressure in order to calculate the mechanical power applied to the lung parenchyma.
The patients included will be those who atend to the intensive care unit of medical centers located in Buenos Aires province, Argetina.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The patients will be put in prone position while receiving invasive mechanical ventilation and the investigators will monitor changes in mechanical power applied to the respiratory system and compare with supine position
Mechanical power of the respiratory system measured in supine compared with prone position while maintaining the same ventilatory setting
Mechanical power measured in Joules/min
Time frame: 1) Supine position; 2) Prone position, after 15 min
Mechanical power of the respiratory system measured in supine compared with prone position after adjusting the ventilatory setting
Mechanical power measured in Joules/min
Time frame: 1) Supine position; 2) Prone position, after 15 min of adjusting ventilatory setting.
Plan to share: No
Ran from May 2020 to primary completion in Sep 2021, 16 months.
Of 228 non-industry observational studies under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 16 months is below that.
Counting every sponsor, half of 234 studies reached it within 24 months; a quarter within 12 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome →
Sanatorio Anchorena San Martin